Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 July 2021 | Story Ruan Bruwer | Photo UFS Photo Archive

Two athletes, both employees of the University of the Free State (UFS), are now giving back to the sport in administrative roles.

Kesa Molotsane and Louzanne Coetzee are making time in their work and training schedules to serve the sports in which they have represented their country – Molotsane in cross-country and Coetzee in the 1 500 m and 800 m T11 category for athletes with a disability.

Louzanne_web content
Louzanne Coetzee Photo: UFS Photo Archive 

Coetzee is again heading for the Paralympic Games in Tokyo. She is a nominee for the International Paralympic Committee Athletes’ Council. Six representatives will be chosen at the Paralympics.

Coetzee was recently elected to the South African Sports Confederation and Olympic Committee Athletes’ Commission. She is also an athlete representative of the South African Sports Association for Physically Disabled.

Molotsane was co-opted into the National Executive Committee of University Sport South Africa as an assessor. She is also the new vice-chairperson of the Athletics South Africa Athletes Commission.

Kesa Molotsane_content
Kesa Molotsane. Photo: Supplied

“My biggest dream is to enable athletes to dream big, and for their dreams to be recognised. I would like to see them enjoy their sport,” said Molotsane.

“I think I probably missed a lot of opportunities in my career due to a lack of funding, so I don’t want to see anyone face the same situation.”

Molotsane was also recently named as one of two ambassadors for the SPAR Grand Prix Series. 

According to Coetzee, a former member of the Student Representative Council at the UFS, she believes that it is important for a current sportsperson to contribute and give input in their sport. 

“I enjoy leadership, it is perhaps a gift of mine. Serving the sport in that capacity is not something that is too much of an effort or takes too much of my time. I enjoy contributing and to see something move in a direction.”

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept